Published on 12 Nov 2021 on Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours.
Johnson & Johnson (NYSE: JNJ) announced its intent to separate its Consumer Health business, creating a new publicly traded company. Following the planned separation, the new Johnson & Johnson would remain a diverse health care company and continue its commitment to lead in global healthcare R&D and innovation, with a portfolio that blends its strong Pharmaceutical and Medical Device capabilities.